About Us Editorial Letter Patients And Caregivers Healthcare Professionals Resources


Post a Query / Comment
 

editorial letter

There have been some practices changing advancements in pancreatic cancer in the last couple of years, the most significant being proof of benefit of  nab-paclitaxel plus gemcitabine and FOLFIRINOX in patients with advanced stage disease. Perceptive commentaries on these advancements have been published on the website. In the meantime, the Editorial Board has been restructured to reflect better multidisciplinary representation of individuals who care for these patients.

In India, we tend to see more peri-ampullary cancers although robust data documenting this fact is lacking. Establishing the pattern of clinical disease in our population is obviously a priority and needs to be undertaken in the context of both hospital and population registries. Some outcome data on pancreatic cancer has been published by Tata Memorial Centre and hopefully other large volume centers will also do so in the near future. In this context it bears reiteration that establishing a pattern and outcome baseline is sine que non for focusing our research priorities as exemplified by the perceived, but as yet undocumented, predominance of periampullary cancers. Moreover, individualized treatment or so-called ‘precision medicine’ is likely to become increasingly prominent in the near future and good quality data will be invaluable in its integration into mainstream management paradigms.  

This year we plan to add more information on pancreatic neuroendocrine tumours, which will hopefully be useful for patients, families and multidisciplinary healthcare professionals.  Also, on our wish list is setting up a Pancreatic Cancer Foundation with the avowed aim of mitigating the lack of funding support for underprivileged patients with pancreatic cancer, which is in contrast to better prognostic cancers such as breast and others. The Foundation will, hopefully, also become an instrument in being able to support relevant and topical research in this deadly malignancy.

The recent consensus reports of the International Study Group of Pancreatic Surgery (ISGPS), published in the journal Surgery, are a step in the right direction. They serve to better define many aspects of pancreatic cancer surgery and also seek to ensure uniformity in documentation across the globe. This website will be following up on these reports with commentaries

We look forward to your continued patronage of this website and valuable suggestions for its evolution…

Bhawna Sirohi, Editor-in-Chief
Shailesh V. Shrikhande, Sudeep Gupta – Editors

July 2014